|
1
|
Franz MJ, Boucher JL, Rutten-Ramos S and
VanWormer JJ: Lifestyle weight-loss intervention outcomes in
overweight and obese adults with type 2 diabetes: A systematic
review and meta-analysis of randomized clinical trials. J Acad Nutr
Diet. 115:1447–1463. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
de Almeida Barreto FK, Montenegro RM Jr,
Fernandes VO, Oliveira R, de AraUjo Batista LA, Hussain A and de
Góes Cavalcanti LP: Chikungunya and diabetes, what do we know?
Diabetol Metab Syndr. 10:322018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Thirunavukkarasu M, Penumathsa SV, Koneru
S, Juhasz B, Zhan L, Otani H, Bagchi D, Das DK and Maulik N:
Resveratrol alleviates cardiac dysfunction in
streptozotocin-induced diabetes: Role of nitric oxide, thioredoxin,
and heme oxygenase. Free Radic Biol Med. 43:720–729. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sotníková R, Nedelčevová J, Navarová J,
Nosáĺová V, Drábiková K, Szöcs K, Křenek P, Kyseĺová Z, Bezek S,
Knezl V, et al: Protection of the vascular endothelium in
experimental situations. Interdiscip Toxicol. 4:20–26. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bulhak AA, Jung C, Ostenson CG, Lundberg
JO, Sjoquist PO and Pernow J: PPAR-alpha activation protects the
type 2 diabetic myocardium against ischemia-reperfusion injury:
Involvement of the PI3-Kinase/Akt and NO pathway. Am J Physiol
Heart Circ Physiol. 296:H719–H727. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang J and Li J: Activated protein C: A
potential cardioprotective factor against ischemic injury during
ischemia/reperfusion. Am J Transl Res. 1:381–392. 2009.PubMed/NCBI
|
|
7
|
Korkmaz-Icöz S, Lehner A, Li S, Vater A,
Radovits T, Hegedűs P, Ruppert M, Brlecic P, Zorn M, Karck M and
Szabó G: Mild type 2 diabetes mellitus reduces the susceptibility
of the heart to ischemia/reperfusion injury: Identification of
underlying gene expression Changes. J Diabetes Res 2015.
3964142015.
|
|
8
|
Wang S, Wang C, Yan F, Wang T, He Y, Li H,
Xia Z and Zhang Z: N-acetylcysteine attenuates diabetic myocardial
ischemia reperfusion injury through inhibiting excessive autophagy.
Mediators Inflamm 2017. 92572912017.
|
|
9
|
Moens AL, Claeys MJ, Timmermans JP and
Vrints CJ: Myocardial ischemia/reperfusion-injury, a clinical view
on a complex pathophysiological process. Int J Cardiol.
100:179–190. 2015. View Article : Google Scholar
|
|
10
|
Feyzizadeh S and Badalzadeh R: Application
of ischemic postconditioning's algorithms in tissues protection:
Response to methodological gaps in preclinical and clinical
studies. J Cell Mol Med. 21:2257–2267. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sabe AA, Elmadhun NY, Dalal RS, Robich MP
and Sellke FW: Resveratrol regulates autophagy signaling in
chronically ischemic myocardium. J Thorac Cardiovasc Surg.
147:792–799. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fernandes GFS, Silva GDB, Pavan AR, Chiba
DE, Chin CM and Dos Santos JL: Epigenetic regulatory mechanisms
induced by resveratrol. Nutrients. 9(pii): E12012017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
He Q, Li Z, Wang Y, Hou Y, Li L and Zhao
J: Resveratrol alleviates cerebral ischemia/reperfusion injury in
rats by inhibiting NLRP3 inflammasome activation through
Sirt1-dependent autophagy induction. Int Immunopharmacol.
50:208–215. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mizushima N: A brief history of autophagy
from cell biology to physiology and disease. Nat Cell Biol.
20:521–527. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gottlieb RA, Finley KD and Mentzer RM Jr:
Cardioprotection requires taking out the trash. Basic Res Cardiol.
104:169–180. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang R, Liu YY, Liu XY, Jia SW, Zhao J,
Cui D and Wang L: Resveratrol protects neurons and the myocardium
by reducing oxidative stress and ameliorating mitochondria damage
in a cerebral ischemia rat model. Cell Physiol Biochem. 34:854–864.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang B, Yang Q, Sun YY, Xing YF, Wang YB,
Lu XT, Bai WW, Liu XQ and Zhao YX: Resveratrol-enhanced autophagic
flux ameliorates myocardial oxidative stress injury in diabetic
mice. J Cell Mol Med. 18:1599–1611. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mukhopadhyay P, Pacher P and Das DK:
MicroRNA signatures of resveratrol in the ischemic heart. Ann N Y
Acad Sci 1215. 109–116. 2011. View Article : Google Scholar
|
|
19
|
Zhang S, Yang J, Li H, Li Y, Liu Y, Zhang
D, Zhang F, Zhou W and Chen X: Skimmin, a coumarin, suppresses the
streptozotocin-induced diabetic nephropathy in wistar rats. Eur J
Pharmacol. 692:78–83. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wu H, Ye M, Liu D, Yang J, Ding JW, Zhang
J, Wang XA, Dong WS and Fan ZX: UCP2 protect the heart from
myocardial ischemia/reperfusion injury via induction of
mitochondrial autophagy. J Cell Biochem. May 13–2019.(Epub ahead of
print). View Article : Google Scholar
|
|
21
|
Joshi MS, Williams D, Horlock D,
Samarasinghe T, Andrews KL, Jefferis AM, Berger PJ, Chin-Dusting JP
and Kaye DM: Role of mitochondrial dysfunction in
hyperglycaemia-induced coronary microvascular dysfunction:
Protective role of resveratrol. Diab Vasc Dis Res. 12:208–216.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Donahoe SM, Stewart GC, McCabe CH,
Mohanavelu S, Murphy SA, Cannon CP and Antman EM: Diabetes and
mortality following acute coronary syndromes. JAMA. 298:765–775.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sabe AA, Elmadhun NY, Robich MP, Dalal RS
and Sellke FW: Does resveratrol improve insulin signaling in
chronically ischemic myocardium? J Surg Res. 183:531–536. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cho S, Namkoong K, Shin M, Park J, Yang E,
Ihm J, Thu VT, Kim HK and Han J: Cardiovascular protective effects
and clinical applications of resveratrol. J Med Food. 20:323–334.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Penumathsa SV and Maulik N: Resveratrol: A
promising agent in promoting cardioprotection against coronary
heart disease. Can J Physiol Pharmacol. 87:275–286. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Welsh SJ, Bellamy WT, Briehl MM and Powis
G: The redox protein thioredoxin-1 (Trx-1) increases
hypoxia-inducible factor 1alpha protein expression: Trx-1
overexpression results in increased vascular endothelial growth
factor production and enhanced tumor angiogenesis. Cancer Res.
62:5089–5095. 2002.PubMed/NCBI
|
|
27
|
Penumathsa SV, Koneru S, Samuel SM, Maulik
G, Bagchi D, Yet SF, Menon VP and Maulik N: Strategic targets to
induce neovascularization by resveratrol in hypercholesterolemic
rat myocardium: Role of caveolin-1, endothelial nitric oxide
synthase, hemeoxygenase-1, and vascular endothelial growth factor.
Free Radic Biol Med. 45:1027–1034. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sakamoto H, Nakamura T, Akuzawa N, Masuda
H, Sumino H, Saito Y, Ohyama Y, Kurashina T, Tamura J and
Kurabayashi M: Reciprocal expression of vascular endothelial growth
factor and nitric oxide synthase by coronary arterial wall cells
during chronic inhibition of nitric oxide synthesis in rats.
Nephron. 92:472–474. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yang Q, Wang HC, Liu Y, Gao C, Sun L and
Tao L: Resveratrol cardioprotection against myocardial
ischemia/reperfusion injury involves upregulation of adiponectin
levels and multimerization in type 2 diabetic mice. J Cardiovasc
Pharmacol. 68:304–312. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Martinet W, Knaapen MW, Kockx MM and De
Meyer GR: Autophagy in cardiovascular disease. Trends Mol Med.
13:482–491. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gustafsson AB and Gottlieb RA: Autophagy
in ischemic heart disease. Circ Res. 104:150–158. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Nishida K, Yamaguchi O and Otsu K:
Crosstalk between autophagy and apoptosis in heart disease. Circ
Res. 103:343–351. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lekli I, Ray D, Mukherjee S, Gurusamy N,
Ahsan MK, Juhasz B, Bak I, Tosaki A, Gherghiceanu M, Popescu LM and
Das DK: Co-ordinated autophagy with resveratrol and γ-tocotrienol
confers synergetic cardioprotection. J Cell Mol Med. 14:2506–2518.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zalckvar E, Berissi H, Eisenstein M and
Kimchi A: Phosphorylation of Beclin 1 by DAP-kinase promotes
autophagy by weakening its interactions with Bcl-2 and Bcl-XL.
Autophagy. 5:720–722. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Matsui Y, Takagi H, Qu X, Abdellatif M,
Sakoda H, Asano T, Levine B and Sadoshima J: Distinct roles of
autophagy in the heart during ischemia and reperfusion: Roles of
AMP-activated protein kinase and Beclin 1 in mediating autophagy.
Circ Res. 100:914–922. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xuan W, Wu B, Chen C, Chen B, Zhang W, Xu
D, Bin J and Liao Y: Resveratrol improves myocardial ischemia and
ischemic heart failure in mice by antagonizing the detrimental
effects of fractalkine*. Crit Care Med. 40:3026–3033. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chen-Scarabelli C, Agrawal PR, Saravolatz
L, Abuniat C, Scarabelli G, Stephanou A, Loomba L, Narula J,
Scarabelli TM and Knight R: The role and modulation of autophagy in
experimental models of myocardial ischemia-reperfusion injury. J
Geriatr Cardiol. 11:338–348. 2014.PubMed/NCBI
|
|
38
|
Liu D, Jin X, Zhang C and Shang Y:
Sevoflurane relieves hepatic ischemia-reperfusion injury by
inhibiting the expression of Grp78. Biosci Rep. 38(pii):
BSR201805492018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liu L, Li X, Yang J, Chai J, Yu Y, Duan H,
Song H, Feng R, Wang T, Yin H, et al: Comparison of systemic
inflammation response and vital organ damage induced by severe
burns in different area. Int J Clin Exp Pathol. 8:6367–6376.
2015.PubMed/NCBI
|
|
40
|
Zhang S, Xin H, Li Y, Zhang D, Shi J, Yang
J and Chen X: Skimmin, a coumarin from hydrangea paniculata, slows
down the progression of membranous glomerulonephritis by
anti-inflammatory effects and inhibiting immune complex deposition.
Evid Based Complement Alternat Med 2013. 8192962013.
|
